Report overview
A method for diagnosing gastrointestinal Stromal Tumor
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Stromal Tumor Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Stromal Tumor Molecular Diagnostics. This report contains market size and forecasts of Gastrointestinal Stromal Tumor Molecular Diagnostics in global, including the following market information:
Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Gastrointestinal Stromal Tumor Molecular Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
PCR Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Gastrointestinal Stromal Tumor Molecular Diagnostics include Yin Feng Gene, KingMed, Geneis, Haplox, AmoyDX, Admera and GeneChem, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gastrointestinal Stromal Tumor Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Segment Percentages, by Type, 2022 (%)
PCR
FISH
DNA Sequencing
Gene Chip
Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Segment Percentages, by Application, 2022 (%)
Clinical Diagnosis
Drug Screening
Research
Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastrointestinal Stromal Tumor Molecular Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gastrointestinal Stromal Tumor Molecular Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Yin Feng Gene
KingMed
Geneis
Haplox
AmoyDX
Admera
GeneChem
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gastrointestinal Stromal Tumor Molecular Diagnostics, market overview.
Chapter 2: Global Gastrointestinal Stromal Tumor Molecular Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Gastrointestinal Stromal Tumor Molecular Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastrointestinal Stromal Tumor Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
